MAP7 and acute myeloid leukemia: Overexpression of MAP7 was further validated by another microarray dataset of peripheral blood (PB) samples [7 CN-AML PB samples (PB samples contained 70–97% blast cells) vs. 10 normal PB (NPB) samples (P = 0.008), GEO accession number GSE9476] (Fig. 1B).